Chang Gung Memorial Hospital clinical trial pipeline

7 trials changed in the last 30 days: 0 stopped, 4 with notable changes, 3 with minor changes only.

1. Notable

   Can Exercise Ameliorate Immunosenescence and Thereby Reduce…Can Exercise Ameliorate Immunosenescence and Thereby Reduce Relapse in Head and Neck Cancer Patients

   Primary completion pushed from Oct 30, 2025 to Oct 30, 2026

   Also in this update: Primary endpoint(s) modified; Enrollment increased: 180 → 290 participants

   Chang Gung Memorial Hospital·Not applicable· NCT06851988· Registry history of NCT06851988 on ClinicalTrials.gov (opens the registry)

   Sep 24, 2026

2. Notable

   Outcome of Injured Cervical Spinal Cord With Uncontrolled Swelling…Outcome of Injured Cervical Spinal Cord With Uncontrolled Swelling Under Duraplasty

   Primary completion pushed from Aug 1, 2025 to Dec 1, 2026

   Also in this update: Trial status changed: Unknown → Recruiting; Study completion pushed from Aug 1, 2026 to Dec 1, 2027

   Chang Gung Memorial Hospital·Not applicable· NCT06552507· Registry history of NCT06552507 on ClinicalTrials.gov (opens the registry)

   Sep 24, 2026

3. Notable

   Dinutuximab-beta and Chemotherapy in Newly Diagnosed High-Risk…Dinutuximab-beta and Chemotherapy in Newly Diagnosed High-Risk Neuroblastoma

   Recruitment opened

   Chang Gung Memorial Hospital·Phase 1· NCT07688252· Registry history of NCT07688252 on ClinicalTrials.gov (opens the registry)

   Oct 6, 2026

4. Notable

   Measurement of Antioxidant Activity and Oxidative Stress in…Measurement of Antioxidant Activity and Oxidative Stress in Patients Undergoing Ophthalmic Surgery

   Final enrollment: 60 participants — 6% of the 1000 planned

   Also in this update: Trial completed; Study completion date changed from estimate of Nov 2025 to Mar 29, 2026

   Chang Gung Memorial Hospital·Not specified· NCT06743594· Registry history of NCT06743594 on ClinicalTrials.gov (opens the registry)

   Oct 6, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.